Literature DB >> 21278882

The twenty-first century role of Piver-Rutledge type III radical hysterectomy and FIGO stage IA, IB1, and IB2 cervical cancer in the era of robotic surgery: a personal perspective.

M Steven Piver1, Ali Ghomi.   

Abstract

Type III radical hysterectomy reported in 1974 by Piver, Rutledge, and Smith is considered worldwide by many as the standard surgical therapy for invasive cervical carcinoma stage IB and IIA. With the increasing number of robotic surgeries being performed for early stage cervical cancer worldwide, the purpose of the paper is to present our personal perspective of the 21st century role of Piver-Rutledge type III radical hysterectomy for stage IB cervical cancer in the era of robotic surgery using the da Vinci robot.

Entities:  

Keywords:  Cervix cancer; Robotic surgey; Type III radical hysterectomy

Year:  2010        PMID: 21278882      PMCID: PMC3026299          DOI: 10.3802/jgo.2010.21.4.219

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  30 in total

1.  Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection.

Authors:  C R Nezhat; M O Burrell; F R Nezhat; B B Benigno; C E Welander
Journal:  Am J Obstet Gynecol       Date:  1992-03       Impact factor: 8.661

Review 2.  Robotic surgery in gynecology.

Authors:  J F Magrina
Journal:  Eur J Gynaecol Oncol       Date:  2007       Impact factor: 0.196

3.  Revised FIGO staging for carcinoma of the cervix.

Authors:  Sergio Pecorelli; Lucia Zigliani; Franco Odicino
Journal:  Int J Gynaecol Obstet       Date:  2009-04-01       Impact factor: 3.561

Review 4.  Cervical cancer.

Authors:  David H Moore
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

5.  Robotically assisted laparoscopic radical hysterectomy compared with open radical hysterectomy.

Authors:  John P Geisler; Curtis J Orr; Naumann Khurshid; Garth Phibbs; Kelly J Manahan
Journal:  Int J Gynecol Cancer       Date:  2010-04       Impact factor: 3.437

6.  Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.

Authors:  M S Piver; W S Chung
Journal:  Obstet Gynecol       Date:  1975-11       Impact factor: 7.661

7.  Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience.

Authors:  Leigh A Cantrell; Alberto Mendivil; Paola A Gehrig; John F Boggess
Journal:  Gynecol Oncol       Date:  2010-02-13       Impact factor: 5.482

8.  Robotic-assisted laparoscopic radical hysterectomy (Piver type III) with pelvic node dissection--case report.

Authors:  B M Sert; V M Abeler
Journal:  Eur J Gynaecol Oncol       Date:  2006       Impact factor: 0.196

Review 9.  Recent advances in the surgical management of cervical cancer.

Authors:  Konstantin Zakashansky; William H Bradley; Linus Chuang; Jamal Rahaman; Peter Dottino
Journal:  Mt Sinai J Med       Date:  2009-12

Review 10.  Advances in surgical management of cervical cancer.

Authors:  A Ercoli; V Iannone; F Legge; A Fagotti; F Fanfani; V Carone; M D'Asta; G Scambia; G Ferrandina
Journal:  Minerva Ginecol       Date:  2009-06
View more
  4 in total

1.  Lower urinary tract dysfunction and quality of life in cervical cancer survivors after concurrent chemoradiation versus radical hysterectomy.

Authors:  Chanita Katepratoom; Tarinee Manchana; Napapat Amornwichet
Journal:  Int Urogynecol J       Date:  2013-07-02       Impact factor: 2.894

2.  Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.

Authors:  Keisuke Tsuchida; Naoya Murakami; Tomoyasu Kato; Kae Okuma; Hiroyuki Okamoto; Tairo Kashihara; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Yuko Nakayama; Takashi Nakano; Jun Itami
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

3.  Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer.

Authors:  Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Young-Seok Kim; Ha Jeong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Seung Jae Huh; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

4.  Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.

Authors:  Maria Lee; Chel Hun Choi; Yi Kyeong Chun; Yun Hwan Kim; Kwang Beom Lee; Shin Wha Lee; Seung Hyuk Shim; Yong Jung Song; Ju Won Roh; Suk Joon Chang; Jong Min Lee
Journal:  J Gynecol Oncol       Date:  2016-08-19       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.